Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 20; pp. e84 - e87
Main Authors Godbert, Yann, Henriques de Figueiredo, Bénédicte, Bonichon, Françoise, Chibon, Frédéric, Hostein, Isabelle, Pérot, Gaëlle, Dupin, Camille, Daubech, Agnès, Belleannée, Genevieve, Gros, Audrey, Italiano, Antoine, Soubeyran, Isabelle
Format Journal Article
LanguageEnglish
Published United States American Society of Clinical Oncology 10.07.2015
Subjects
Aged
Antineoplastic Agents - therapeutic use
Biomarkers, Tumor - genetics
Biopsy
Cancer
Chemotherapy, Adjuvant
Female
Gene Rearrangement
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Life Sciences
Lung Neoplasms - drug therapy
Lung Neoplasms - enzymology
Lung Neoplasms - genetics
Lung Neoplasms - secondary
Neoplasm Staging
Precision Medicine
Predictive Value of Tests
Protein Kinase Inhibitors - therapeutic use
Pyrazoles - therapeutic use
Pyridines - therapeutic use
Receptor Protein-Tyrosine Kinases - antagonists & inhibitors
Receptor Protein-Tyrosine Kinases - genetics
Remission Induction
Thyroid Carcinoma, Anaplastic - drug therapy
Thyroid Carcinoma, Anaplastic - enzymology
Thyroid Carcinoma, Anaplastic - genetics
Thyroid Carcinoma, Anaplastic - secondary
Thyroid Neoplasms - drug therapy
Thyroid Neoplasms - enzymology
Thyroid Neoplasms - genetics
Thyroid Neoplasms - pathology
Thyroidectomy
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Online AccessGet full text
ISSN0732-183X
1527-7755
1527-7755
DOI10.1200/JCO.2013.49.6596

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0732-183X
1527-7755
1527-7755
DOI:10.1200/JCO.2013.49.6596